These novel treatments, Tirzepatide , represent a significant advancement in managing obesity and conceivably related conditions . They are grouped as GLP-1 hormone stimulators, signifying they function to mimic the natural GLP-1 peptide, enhancing insulin release and lowering food intake. Despit